2017
Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification.
Wijnenga MMJ, Dubbink HJ, French PJ, Synhaeve NE, Dinjens WNM, Atmodimedjo PN, Kros JM, Dirven CMF, Vincent AJPE, van den Bent MJ.
Acta Neuropathol. 2017 Dec;134(6):957-959. doi: 10.1007/s00401-017-1781-z

The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological and molecular analysis.
Wijnenga MMJ, French PJ, Dubbink HJ, Dinjens WNM, Atmodimedjo PN, Kros JM, Smits M, Gahrmann R, Rutten GJ, Verheul JB, Fleischeuer R, Dirven CMF, Vincent AJPE, van den Bent MJ.
Neuro Oncol. 2017 Sep 7. doi: 10.1093/neuonc/nox176.

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.
Weller M, van den Bent M, Tonn JC, Stupp R, Preusser M, Cohen-Jonathan-Moyal E, Henriksson R, Le Rhun E, Balana C, Chinot O, Bendszus M, Reijneveld JC, Dhermain F, French P, Marosi C, Watts C, Oberg I, Pilkington G, Baumert BG, Taphoorn MJB, Hegi M, Westphal M, Reifenberger G, Soffietti R, Wick W; European Association for Neuro-Oncology (EANO) Task Force on Gliomas
Lancet Oncol. 2017 Jun;18(6):e315-e329.

Does early resection of presumed low-grade glioma improve survival? A clinical perspective.
Wijnenga MMJ, Mattni T, French PJ, Rutten GJ, Leenstra S, Kloet F, Taphoorn MJB, van den Bent MJ, Dirven CMF, van Veelen ML, Vincent AJPE.
J Neurooncol. 2017 May;133(1):137-146

Intertumoral Heterogeneity within Medulloblastoma Subgroups.
Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K, Daniels C, Cho BK, Kim SK, Wang KC, Lee JY, Grajkowska WA, Perek-Polnik M, Vasiljevic A, Faure-Conter C, Jouvet A, Giannini C, Nageswara Rao AA, Li KKW, Ng HK, Eberhart CG, Pollack IF, Hamilton RL, Gillespie GY, Olson JM, Leary S, Weiss WA, Lach B, Chambless LB, Thompson RC, Cooper MK, Vibhakar R, Hauser P, van Veelen MC, Kros JM, French PJ, Ra YS, Kumabe T, López-Aguilar E, Zitterbart K, Sterba J, Finocchiaro G, Massimino M, Van Meir EG, Osuka S, Shofuda T, Klekner A, Zollo M, Leonard JR, Rubin JB, Jabado N, Albrecht S, Mora J, Van Meter TE, Jung S, Moore AS, Hallahan AR, Chan JA, Tirapelli DPC, Carlotti CG, Fouladi M, Pimentel J, Faria CC, Saad AG, Massimi L, Liau LM, Wheeler H, Nakamura H, Elbabaa SK, Perezpeña-Diazconti M, Chico Ponce de León F, Robinson S, Zapotocky M, Lassaletta A, Huang A, Hawkins CE, Tabori U, Bouffet E, Bartels U, Dirks PB, Rutka JT, Bader GD, Reimand J, Goldenberg A, Ramaswamy V, Taylor MD.
Cancer Cell. 2017 Jun 12;31(6):737-754

Unique intrahepatic transcriptomics profiles discriminate the clinical phases of a chronic HBV infection.
Hou J, Brouwer WP, Kreefft K, Gama L, Price SL, Janssen HLA, French PJ, Vanwolleghem T, Boonstra A.
PLoS One. 2017 Jun 29;12(6):e0179920.


2016

Identification of patients with recurrent glioblastoma who may benefit from combined bevacizumab and CCNU therapy, a report from the BELOB trial.
Erdem-Eraslan L, van den Bent MJ, Hoogstrate Y, Naz-Khan H, Stubbs A, van der Spek P, Böttcher R, Gao Y, de Wit M, Taal W, Oosterkamp HM, Walenkamp A, Beerepoot LV, Hanse MCJ, Buter J, Honkoop AH, van der Holt B, Vernhout RM, Sillevis Smitt PA, Kros JM, French PJ. 
Cancer Res 2016 76(3):525-34

Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.
Thompson EM, Hielscher T, Bouffet E, Remke M, Luu B, Gururangan S, McLendon RE, Bigner DD, Lipp ES, Perreault S, Cho YJ, Grant G, Kim SK, Lee JY, Rao AA, Giannini C, Li KK, Ng HK, Yao Y, Kumabe T, Tominaga T, Grajkowska WA, Perek-Polnik M, Low DC, Seow WT, Chang KT, Mora J, Pollack IF, Hamilton RL, Leary S, Moore AS, Ingram WJ, Hallahan AR, Jouvet A, Fèvre-Montange M, Vasiljevic A, Faure-Conter C, Shofuda T, Kagawa N, Hashimoto N, Jabado N, Weil AG, Gayden T, Wataya T, Shalaby T, Grotzer M, Zitterbart K, Sterba J, Kren L, Hortobágyi T, Klekner A, László B, Pócza T, Hauser P, Schüller U, Jung S, Jang WY, French PJ, Kros JM, van Veelen ML, Massimi L, Leonard JR, Rubin JB, Vibhakar R, Chambless LB, Cooper MK, Thompson RC, Faria CC, Carvalho A, Nunes S, Pimentel J, Fan X, Muraszko KM, López-Aguilar E, Lyden D, Garzia L, Shih DJ, Kijima N, Schneider C, Adamski J, Northcott PA, Kool M, Jones DT, Chan JA, Nikolic A, Garre ML, Van Meir EG, Osuka S, Olson JJ, Jahangiri A, Castro BA, Gupta N, Weiss WA, Moxon-Emre I, Mabbott DJ, Lassaletta A, Hawkins CE, Tabori U, Drake J, Kulkarni A, Dirks P, Rutka JT, Korshunov A, Pfister SM, Packer RJ, Ramaswamy V, Taylor MD.
Lancet Oncol. 2016 Apr;17(4):484-95. 

A validated microRNA profile with predictive potential in glioblastoma patients treated with bevacizumab.
Hayes J, Thygesen H, Gregory W, Westhead DR, French PJ, Van Den Bent MJ, Lawler SE, Short SC.
Mol Oncol. 2016 Oct;10(8):1296-304.

Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
Dubbink HJ, Atmodimedjo PN, Kros JM, French PJ, Sanson M, Idbaih A, Wesseling P, Enting R, Spliet W, Tijssen C, Dinjens WN, Gorlia T, van den Bent MJ.
Neuro Oncol. 2016 Mar;18(3):388-400


2015
PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K, Wijnenga MM, Weenink B, Gao Y, Smid M, Robe P, van den Bent MJ, French PJ.
Acta Neuropathol Commun. 2015 Dec 23;3(1):88.

Evidence-Based Diagnostic Algorithm for Glioma: Analysis of the Results of Pathology Panel Review and Molecular Parameters of EORTC 26951 and 26882 Trials.
Kros JM, Huizer K, Hernández-Laín A, Marucci G, Michotte A, Pollo B, Rushing EJ, Ribalta T, French P, Jaminé D, Bekka N, Lacombe D, van den Bent MJ, Gorlia T.
J Clin Oncol. 2015 Apr 27 [IF 2013: 17.9]

Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation
Erdem-Eraslan L, Gao Y, Kloosterhof NK, Atlasi Y, Demmers J, Sacchetti A, Kros JM, Sillevis Smitt PA, Aerts J, French PJ.
Eur. J. Cancer, 51(7):893-903 [IF 2013: 4.8]

Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas. MJ van den Bent, Y Gao, M Kerkhof, JM Kros, T Gorlia, K van Zwieten, J Prince, S van Duinen, PA Sillevis Smitt, M Taphoorn, PJ French. Neuro-Oncology,17(7):935-41 [IF 2013: 5.3]

Tumor-specific mutations in low-frequency genes affect their functional properties.Erdem-Eraslan L, Heijsman D, de Wit M, Kremer A, Sacchetti A, Van der Spek P, Sillevis Smitt PAE, French PJ. J. Neuro-Oncology, 122(3):461-70. [IF 2013: 2.9]

Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
Dubbink HJ, Atmodimedjo PN, Kros JM, French PJ, Sanson M, Idbaih A, Wesseling P, Enting R, Spliet W, Tijssen C, Dinjens WN, Gorlia T, van den Bent MJ. Neuro Oncol. 2015 Sep 9  [IF 2013: 5.3]



2014
A glioma classification scheme based on coexpression modules of EGFR and PDGFRA. 
Sun Y, Zhang W, Chen D, Lv Y, Zheng J, Lilljebjörn H, Ran L, Bao Z, Soneson C, Sjögren HO, Salford LG, Ji J, French PJ, Fioretos T, Jiang T, Fan X. Proc Natl Acad Sci U S A. 2014 Feb 18;. [IF 2013: 9.8]

WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma.
Zhukova N, Ramaswamy V, Remke M, Martin DC, Castelo-Branco P, Zhang CH, Fraser M, Tse K, Poon R, Shih D, Baskin B, Ray PN, Bouffet E, Dirks P, von Bueren AO, Pfaff E, Korshunov A, Jones D, Northcott PA, Kool M, Pugh TJ, Pomeroy SL, Cho YJ, Pietsch T, Gessi M, Rutkowski S, Bognár L, Cho BK, Eberhart CG, Conter C, Fouladi M, French PJ, Grajkowska WA, Gupta N, Hauser P, Jabado N, Vasiljevic A, Jung S, Kim SK, Klekner A, Kumabe T, Lach B, Leonard JR, Liau LM, Massimi L, Pollack IF, Ra Y, Rubin JB, Van Meir EG, Wang KC, Weiss WA, Zitterbart K, Bristow RG, Alman B, Hawkins CE, Malkin D, Clifford SC, Pfister SM, Taylor MD, Tabori U. 
Acta Neuropathol Commun. 2014 Dec 24;2(1):3.

Cytogenetic Prognostication within Medulloblastoma Subgroups.
David Shih, Paul A Northcott, Marc Remke, Andrey Korshunov, Vijay Ramaswamy, Marcel Kool, Betty Luu, Yuan Yao, Kevin Xin Wang, Adrian Dubuc, Livia Garzia, John Peacock, Stephen Mack, Xiaochong Wu, Adi Rolider, Sorana Morrissy, Florence Cavalli, David TW Jones, Karel Zitterbart, Claudia Faria, Ulrich Schüller, Leos Kren, Toshihiro Kumabe, Teiji Tominaga, Young-shin Ra, Miklos Garami, Peter Hauser, Jennifer A Chan, Shenandoah Robinson, laszlo bognar, Almos Klekner, Ali G Saad, Linda Liau, Steffen Albrecht, Adam Fontebasso, Giuseppe Cinalli, Pasqualino De Antonellis, Massimo Zollo, Michael K Cooper, Reid C Thompson, Simon Bailey, Janet C Lindsey, Concezio Di Rocco, luca massimi, Erna Michiels, Stephen W Scherer, Joanna J Phillips, Nalin Gupta, Xing Fan, Karin M Muraszko, Rajeev Vibhakar, Charles Eberhart, Maryam Fouladi, Boleslaw Lach, Shin Jung, Robert J Wechsler-Reya, Michelle Fèvre-Montange, Anne Jouvet, Nada Jabado, Ian Pollack, William A Weiss, Ji-Yeoun Lee, Byung-Kyu Cho, Seung-Ki Kim, Kyu-Chang Wang, Jeffrey Leonard, Joshua Rubin, Carmen de Torres, Cinzia Lavarino, Jaume Mora, Yoon-Jae Cho, Uri Tabori, James Olson, Amar Gajjar, Roger J Packer, Stefan Rutkowski, Scott Pomeroy, Pim French, Nanne K Kloosterhof, Johan Kros, Erwin Van Meir, Steven C Clifford, Franck Bourdeaut, Olivier Delattre, Francois Doz, Cynthia Hawkins, David Malkin, Wieslawa A Grajkowska, Marta Perek-Polnik, Eric Bouffet, James Rutka, Stefan M Pfister, and Michael D Taylor.
J. Clin Oncol (2014) 32: 886-96 [IF 2013: 17.9]



2013
MGMT-STP27 methylation status as Predictive Marker for Response to PCV in Anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951.
van den Bent MJ, Erdem Eraslan L, Idbaih A, de Rooi JJ, Eilers PH, Spliet W, den Dunnen WF, Tijssen C, Wesseling P, Sillevis Smitt PA, Kros JM, Gorlia T, French PJ.
Clin Cancer Res. 2013 Aug 15. [IF 2013: 8.2]

Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951.
Erdem-Eraslan L, Gravendeel LA, de Rooi J, Eilers PHC, Idbaih A, Spliet WGM, den Dunnen WFA, Teepen JL, Wesseling P, Sillevis Smitt PAE, Kros JM, Gorlia T, van den Bent MJ, French PJ. 
J. Clin Oncol (2013) 31:328-36 [IF 2013: 17.9].

Serum-free culture success of glial tumors is related to specific molecular profiles and expression of extracellular matrix-associated gene modules.
Balvers RK, Kleijn A, Kloezeman JJ, French PJ, Kremer A, van den Bent MJ, Dirven CM, Leenstra S, Lamfers ML.
Neuro Oncol. 2013 Sep 17 [IF 2013: 5.3]

Molecular subtypes of glioma identified by genome-wide methylation profiling. 
Kloosterhof NK, de Rooi, JJ, Kros JM, Eilers PHC, Sillevis Smitt PAE, van den Bent MJ, FrenchPJ.
Genes Chrom Cancer, 52:665-74 [IF 2013: 3.8]

Structural and expression differences between the vasculature of pilocytic astrocytomas and glioblastomas. 
Mustafa D, Swagemakers S, French P, Luider TM, van der Spek P, Kremer A, Kros JM. 
J Neuropathol Exp Neurol. 2013 Dec;72(12):1171-81 [IF2013: 4.4]

Raman spectroscopy can discriminate distinct glioma subtypes as defined by RNA expression profiling.
Jachtenberg J-W, Bakker Schut T, French P, Kros M, Lamfers M, Leenstra S.
J Raman Spectrosc (2013) 44:1217–21 [IF 2013: 2.5]
 
Adjuvant PCV chemotherapy in newly diagnosed anaplastic oligodendroglioma – long term follow-up of EORTC Brain Tumor Group study 26951. 
van den Bent MJ, Brandes AA, Taphoorn MJ, Kros JM, Kouwenhoven MC, Delattre J-Y, Bernsen HJ, Frenay M, Tijssen CC, Grisold W,  Sipos L, Enting RH, French PJ, Dinjens WN, Vecht CJ, Allgeier A, Lacombe D, Gorlia T, Hoang-Xuan K. On Behalf of the European Organisation for Research and Treatment of Cancer Brain Tumor Group.
J. Clin Oncol (2013) 
31:344-50 [IF 2013: 17.9]. 

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. 
Remke M, Ramaswamy V, Peacock J, Shih DJ, Koelsche C, Northcott PA, Hill N, Cavalli FM, Kool M, Wang X, Mack SC, Barszczyk M, Morrissy AS, Wu X, Agnihotri S, Luu B, Jones DT, Garzia L, Dubuc AM, Zhukova N, Vanner R, Kros JM, French PJ, Van Meir EG, Vibhakar R, Zitterbart K, Chan JA, Bognár L, Klekner A, Lach B, Jung S, Saad AG, Liau LM, Albrecht S, Zollo M, Cooper MK, Thompson RC, Delattre OO, Bourdeaut F, Doz FF, Garami M, Hauser P, Carlotti CG, Van Meter TE, Massimi L, Fults D, Pomeroy SL, Kumabe T, Ra YS, Leonard JR, Elbabaa SK, Mora J, Rubin JB, Cho YJ, McLendon RE, Bigner DD, Eberhart CG, Fouladi M, Wechsler-Reya RJ, Faria CC, Croul SE, Huang A, Bouffet E, Hawkins CE, Dirks PB, Weiss WA, Schüller U, Pollack IF, Rutkowski S, Meyronet D, Jouvet A, Fèvre-Montange M, Jabado N, Perek-Polnik M, Grajkowska WA, Kim SK, Rutka JT, Malkin D, Tabori U, Pfister SM, Korshunov A, von Deimling A, Taylor MD. 
Acta Neuropathol. 2013 Dec;126(6):917-29 [IF2013: 9.8]

Subgroup Specific Prognostic Implications of TP53 Mutation in Medulloblastoma.
Zhukova N, Ramaswamy V, Remke M, Shih DJH, Martin DC, Castelo-Branco P, Baskin B, Ray PN, Bouffet E, von Bueren A, Pfaff E, Korshunov A, Jones DTW, Northcott PA, Kool M, Pugh T, Pomeroy SL, Cho Y-J, Pietsch T, Gessi M, Rutkowski S, Bogntr L, Klekner A, Cho B-K, Kim S-K, Wang K-C, Eberhart CG, Fevre-Montange M, Fouladi M, French PJ, Kros M, Grajkowska WA, Gupta N, Weiss WA, Hauser P, Jabado N, Jouvet A, Jung S, Kumabe T, Lach B, Leonard JR, Rubin JB, Liau LM, Massimi L, Pollack IF, Shin Ra Y, Van Meir EG, Zitterbart K, Schüller U, Hill RM, Lindsey JC, Schwalbe EC, Bailey S, Ellison DW, Hawkins C, Malkin D, Clifford S, Pfister S, Taylor MD, Tabor U. 
J. Clin Oncol (2013) accepted for publication [IF 2013: 17.9]

The CpG island methylator phenotype: what's in a name?
Hughes LA, Melotte V, de Schrijver J, de Maat M, Smit VT, Bovee JV, French PJ, van den Brandt PA, Schouten LJ, de Meyer T, Van Criekinge W, Ahuja N, Herman JG, Weijenberg MP, van Engeland M.
Cancer Res. 2013 Jun 25 [IF2013: 9.3]

Mutations in the isocitrate dehydrogenase genes IDH1 and IDH2 in tumors.
Schaap FG, French PJ, Bovée JV.
Adv Anat Pathol. 2013;20(1):32-8 [IF 2013: 3.1]



2012
Subgroup-specific structural variation across 1,000 medulloblastoma genomes. 
Northcott PA, Shih DJ, Peacock J, Garzia L, Morrissy AS, Zichner T, Stütz AM, Korshunov A, Reimand J, Schumacher SE, Beroukhim R, Ellison DW, Marshall CR, Lionel AC, Mack S, Dubuc A, Yao Y, Ramaswamy V, Luu B, Rolider A, Cavalli FM, Wang X, Remke M, Wu X, Chiu RY, Chu A, Chuah E, Corbett RD, Hoad GR, Jackman SD, Li Y, Lo A, Mungall KL, Nip KM, Qian JQ, Raymond AG, Thiessen NT, Varhol RJ, Birol I, Moore RA, Mungall AJ, Holt R, Kawauchi D, Roussel MF, Kool M, Jones DT, Witt H, Fernandez-L A, Kenney AM, Wechsler-Reya RJ, Dirks P, Aviv T, Grajkowska WA, Perek-Polnik M, Haberler CC, Delattre O, Reynaud SS, Doz FF, Pernet-Fattet SS, Cho BK, Kim SK, Wang KC, Scheurlen W, Eberhart CG, Fèvre-Montange M, Jouvet A, Pollack IF, Fan X, Muraszko KM, Gillespie GY, Di Rocco C, Massimi L, Michiels EM, Kloosterhof NK, French PJ, Kros JM, Olson JM, Ellenbogen RG, Zitterbart K, Kren L, Thompson RC, Cooper MK, Lach B, McLendon RE, Bigner DD, Fontebasso A, Albrecht S, Jabado N, Lindsey JC, Bailey S, Gupta N, Weiss WA, Bognár L, Klekner A, Van Meter TE, Kumabe T, Tominaga T, Elbabaa SK, Leonard JR, Rubin JB, Liau LM, Van Meir EG, Fouladi M, Nakamura H, Cinalli G, Garami M, Hauser P, Saad AG, Iolascon A, Jung S, Carlotti CG, Vibhakar R, Ra YS, Robinson S, Zollo M, Faria CC, Chan JA, Levy ML, Sorensen PH, Meyerson M, Pomeroy SL, Cho YJ, Bader GD, Tabori U, Hawkins CE, Bouffet E, Scherer SW, Rutka JT, Malkin D, Clifford SC, Jones SJ, Korbel JO, Pfister SM, Marra MA, Taylor MD. 
Nature (2012) 488:49-56. [IF 2012: 38.6]. 

Subgroup-specific alternative splicing in medulloblastoma. 
Dubuc AM, Morrissy AS, Kloosterhof NK, Northcott PA, Yu EP, Shih D, Peacock J, Grajkowska W, van Meter T, Eberhart CG, Pfister S, Marra MA, Weiss WA, Scherer SW, Rutka JT, French PJ, Taylor MD. 
Acta Neuropathol (2012) 123:485-99  [IF 2012: 9.7] 


2011
Gene expression profiling of gliomas in formalin-fixed paraffin-embedded material.
Gravendeel LA, de Rooi JJ, Eilers PHC, van den Bent MJ, Sillevis Smitt PAE, French PJ. 
Brit J Cancer (2011), 106:538-45  [IF in 2011: 5.0]

Somatic mosaic IDH1 orIDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome.
Pansuriya, TC, van Eijk R, de Adamo P, van Ruler M, Kuijjer M, Oosting J, Cleton-Jansen A, van Oosterwijk JG, Verbeke S, Meijer D, van Wezel T, Nord KH, Sangiorgi L, Toker B, Liegl-Atzwanger B, San-Julian M, Sciot R, Limaye N, Kindblom L, Daugaard S, Godfraind C, Boon, LM, Vikkula M, Kurek KC, Szuhai K, French PJ, Bovée JVGM.  
Nature genetics (2011) 43:1256-61 [IF 2011: 35.5]

IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo. 
Bralten LBC, Kloosterhof NK, Balvers R, Sacchetti A, Lapre L, Lamfers M, Leenstra S, de Jonge HR, Kros JM, Jansen EEW, Struys EA Jakobs C, Salomons GS, Diks SH, Peppelenbosch M, Kremer A, Hoogenraad CC, Sillevis Smitt PAE, French PJ.
Ann Neurol (2011); 69:455-63 [IF in 2011: 11.1]

A Hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951. 
van den Bent MJ, Gravendeel LA, Gorlia T, Kros JM, Lapre L, Wesseling P, Teepen JL, Adbaih A, Sanson M, Sillevis Smitt PAE, French PJ.
Clin Can Res (2011); 17:1748-55  [IF in 2011: 7.7]
 
Absence of common somatic alterations in genes on 1p and 19q in oligodendrogliomas. 
Bralten LB, Nouwens S, Kockx C, Erdem L, Hoogenraad CC, Kros JM, Moorhouse MJ, Sillevis Smitt PAE, van der Spek P, van Ijcken W, Stubbs A, French PJ. 
Plos One (2011), 6: e22000 [IF in 2011: 4.1]

Detailed characterization of alterations of chromosomes 7, 9 and 10 in glioblastomas as assessed by single nucleotide polymorphism arrays.
Crespo I, Vital AL, Nieto AB, Rebelo O, Tao H, Lopes MC, Oliviera CR, French PJ, Orfao A, Tabernero MD.
J Mol Diagn (2011), aug29 [IF in 2011: 3.6]

Molecular subtypes of glioma.
Gravendeel LA, French PJ. 
Chapter 3 in: Tumors of the central nervous system (Springer Book). Editor E. Hayat.

Genetic Alterations in Glioma. 
Bralten LBC, French PJ.
Cancers (2011); 3, 1129-1140


2010
The CASPR2 cell adhesion molecule functions as a tumor suppressor gene in glioma. 
Bralten LB, Gravendeel AM, Kloosterhof NK, Sacchetti A, Vrijenhoek T, Veltman JA, van den Bent MJ, Kros JM, Hoogenraad CC, Sillevis Smitt PA, French PJ. 
Oncogene. (2010); 29:6138-48 [IF in 2010: 7.4]

Medulloblastoma comprises four distinct diseases. 
Norcott PA, Korshunov A, Witt H, Hielscher T, Eberhart C, Mack S, Bouffet E, Clifford S, Hawkins C, French P, Rutka J, Pfister S, Taylor MD 
J Clin Oncol (2010); 29:1408-14 [IF 2010: 19.0]

Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma. 
Gravendeel LA, Kloosterhof NK, Bralten LB, van Marion R, Dubbink HJ, Dinjens W, Bleeker FE, Hoogenraad CC, Michiels E, Kros JM, van den Bent M, Sillevis Smitt PA, French PJ. 
Human Mutation (2010); 31(3):1186-99 [IF in 2010: 6.0]

IDH1 mutations: a fundamentally new understanding of diffuse glioma? 
Kloosterhof NK, Bralten LB, French PJ, van den Bent MJ. 
Lancet Oncol (2010); 12:83-91 [IF in 2010: 17.8]

Integrated genomic profiling identifies candidate genes implicated in glioma-genesis and a novel LEO1-SLC12A1 fusion gene. 
Bralten LB, Kloosterhof NK, Gravendeel LA, Sacchetti A, Duijm EJ, Kros JM, van den Bent MJ, Hoogenraad CC, Sillevis Smitt PA, French PJ. 
Genes Chromosomes and Cancer (2010); 49(6):509-17 [IF in 2010: 4.0]

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951.
Idbaih A, Dalmasso C, Kouwenhoven M, Jeuken J, Carpentier C, Gorlia T, Kros JM, French PJ, Teepen J, Broët P, Delattre O, Mokhtari K, Sanson M, Delattre J-Y, van den Bent M, Hoang-Xuan K.
J Neuro-Oncol, Sept 6 [IF in 2010:: 2.9]

 
2009
Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. 
Gravendeel LA, Kouwenhoven MC, Gevaert O, de Rooi JJ, Stubbs AP, Duijm JE,  Daemen A, Bleeker FE, Bralten LB, Kloosterhof NK, De Moor B, Eilers PH, van der Spek PJ, Kros JM, Sillevis Smitt PA, van den Bent MJ, French PJ. 
Cancer Res. 2009 Dec 1;69(23):9065-72. Epub 2009 Nov 17. [IF 2009: 7.5]

Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. 
Hollestelle A, Nagel JH, Smid M, Lam S, Elstrodt F, Wasielewski M, Ng SS, French PJ, Peeters JK, Rozendaal MJ, Riaz M, Koopman DG, Ten Hagen TL, de Leeuw BH, Zwarthoff EC, Teunisse A, van der Spek PJ, Klijn JG, Dinjens WN, Ethier SP, Clevers H, Jochemsen AG, den Bakker MA, Foekens JA, Martens JW, Schutte M. 
Breast Cancer Res Treat. 2009 Jul 11. [Epub ahead of print] [IF 2009: 4.7]



2008
Expression of the MAST family of serine/threonine kinases. 
Garland P, Quraishe S, French P, O'Connor V. 
Brain Res. 2008 Feb 21;1195:12-9. Epub 2007 Dec 23. [IF 2008: 2.5]



2007
Exon expression arrays as a tool to identify new cancer genes. 
Schutte M, Elstrodt F, Bralten LB, Nagel JH, Duijm E, Hollestelle A, Vuerhard MJ, Wasielewski M, Peeters JK, van der Spek P, Sillevis Smitt PA, French PJ. 
PLoS One. 2007 Aug 20;3(8):e3007.

Identification of differentially regulated splice variants and novel exons in glial brain tumors using exon expression arrays.
French PJ, Peeters J, Horsman S, Duijm E, Siccama I, van den Bent MJ, Luider TM, Kros JM, van der Spek P, Sillevis Smitt PA. 
Cancer Res. 2007 Jun 15;67(12):5635-42. [IF 2007: 7.7]

Distribution of glycinergic neuronal somata in the rat spinal cord. 
Hossaini M, French PJ, Holstege JC. 
Brain Res. 2007 Apr 20;1142:61-9. Epub 2007 Jan 28. [IF 2007: 2.2]

Echinoderm microtubule-associated protein like protein 4, a member of the echinoderm microtubule-associated protein family, stabilizes microtubules. 
Houtman SH, Rutteman M, De Zeeuw CI, French PJ. 
Neuroscience. 2007 Feb 23;144(4):1373-82. Epub 2006 Dec 27. [IF 2007: 3.4]

Chromosome 1p loss evaluation in anaplastic oligodendrogliomas.
Idbaih A, Kouwenhoven M, Jeuken J, Carpentier C, Gorlia T, Kros JM, French P, Teepen JL, Delattre O, Delattre JY, van den Bent M, Hoang-Xuan K.
Neuropathology. 2008 28(4):440-3. [IF in 2007: 1.3 ]



2006
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment. 
Kouwenhoven MC, Kros JM, French PJ, Biemond-ter Stege EM, Graveland WJ, Taphoorn MJ, Brandes AA, van den Bent MJ. 
Eur J Cancer. 2006 Oct;42(15):2499-503. Epub 2006 Aug 17. [IF 2006: 4.2] 

Spatiotemporal distribution of Connexin45 in the olivocerebellar system. 
Van Der Giessen RS, Maxeiner S, French PJ, Willecke K, De Zeeuw CI. 
J Comp Neurol. 2006 Mar 10;495(2):173-84. [IF 2006: 3.8]



2005
Gene expression profiles associated with treatment response in oligodendrogliomas. 
French PJ, Swagemakers SM, Nagel JH, Kouwenhoven MC, Brouwer E, van der Spek P, Luider TM, Kros JM, van den Bent MJ, Sillevis Smitt PA. 
Cancer Res. 2005 Dec 15;65(24):11335-44. [IF 2005: 7.6]

ATF3 expression precedes death of spinal motoneurons in amyotrophic lateral sclerosis-SOD1 transgenic mice and correlates with c-Jun phosphorylation, CHOP expression, somato-dendritic ubiquitination and Golgi fragmentation.
Vlug AS, Teuling E, Haasdijk ED, French P, Hoogenraad CC, Jaarsma D.
Eur J Neurosci. 2005 22(8):1881-94 [IF in 2005: 3.9]



2004
Decrease of Hsp25 protein expression precedes degeneration of motoneurons in ALS-SOD1 mice. 
Maatkamp A, Vlug A, Haasdijk E, Troost D, French PJ, Jaarsma D. 
Eur J Neurosci. 2004 Jul;20(1):14-28. [IF 2004: 3.8]

Eml5, a novel WD40 domain protein expressed in rat brain. 
O'Connor V, Houtman SH, De Zeeuw CI, Bliss TV, French PJ. 
Gene. 2004 Jul 7;336(1):127-37. [IF 2004: 2.7]

Differential amplification of intron-containing transcripts reveals long term potentiation-associated up-regulation of specific Pde10A phosphodiesterase splice variants. 
O'Connor V, Genin A, Davis S, Karishma KK, Doyère V, De Zeeuw CI, Sanger G, Hunt SP, Richter-Levin G, Mallet J, Laroche S, Bliss TV, French PJ. 
J Biol Chem. 2004 Apr 16;279(16):15841-9. Epub 2004 Jan 28. [IF 2004: 6.4]


2003
LTP but not seizure is associated with up-regulation of AKAP-150.
Génin A, French P, Doyère V, Davis S, Errington ML, Maroun M, Stean T, Truchet B, Webber M, Wills T, Richter-Levin G, Sanger G, Hunt SP, Mallet J, Laroche S, Bliss TV, O'Connor V. 
Eur J Neurosci. 2003 Jan;17(2):331-40. [IF 2003: 3.9]

Deformation of network connectivity in the inferior olive of connexin 36-deficient mice is compensated by morphological and electrophysiological changes at the single neuron level. 
De Zeeuw CI, Chorev E, Devor A, Manor Y, Van Der Giessen RS, De Jeu MT, Hoogenraad CC, Bijman J, Ruigrok TJ, French P, Jaarsma D, Kistler WM, Meier C, Petrasch-Parwez E, Dermietzel R, Sohl G, Gueldenagel M, Willecke K, Yarom Y. 
J Neurosci. 2003 Jun 1;23(11):4700-11. [IF 2003: 8.3]



2002
The role of extracellular regulated kinases I/II in late-phase long-term potentiation.
Rosenblum, K., Futter, M., Voss, K., Erent, M., Skehel, P. A., French, P. J., Obosi, L., Jones, M. W., and Bliss, T. V.
J Neurosci 22, 5432-5441. [IF 8.0 in 2002]



2001
Seizure-induced gene expression in area CA1 of the mouse hippocampus. 
French PJ, O'Connor V, Voss K, Stean T, Hunt SP, Bliss TV. 
Eur J Neurosci. 2001 Dec;14(12):2037-41. [IF 2001: 3.9]

Ntab, a novel non-coding RNA abundantly expressed in rat brain. 
French PJ, Bliss TV, O'Connor V. 
Neuroscience. 2001;108(2):207-15. [IF 2001: 3.2]

Subfield-specific immediate early gene expression associated with hippocampal long-term potentiation in vivo. 
French PJ, O'Connor V, Jones MW, Davis S, Errington ML, Voss K, Truchet B, Wotjak C, Stean T, Doyère V, Maroun M, Laroche S, Bliss TV. 
Eur J Neurosci. 2001 Mar;13(5):968-76. [IF 2001: 3.9]

A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. 
Jones MW, Errington ML, French PJ, Fine A, Bliss TV, Garel S, Charnay P, Bozon B, Laroche S, Davis S. 
Nat Neurosci. 2001 Mar;4(3):289-96. [IF 2001: 15.7]



1999
Molecular mechanisms of long-term potentiation in the insular cortex in vivo. 
Jones MW, French PJ, Bliss TV, Rosenblum K. 
J Neurosci. 1999 Nov 1;19(21):RC36. [IF 1999: 9.0]



1997
Genistein activates CFTR Cl- channels via a tyrosine kinase- and protein phosphatase-independent mechanism. 
French PJ, Bijman J, Bot AG, Boomaars WE, Scholte BJ, de Jonge HR.
Am J Physiol. 1997 Aug;273(2 Pt 1):C747-53. [IF 1997: 3.1]

Cystic fibrosis transmembrane conductance regulator mediates the cyclic adenosine monophosphate-induced fluid secretion but not the inhibition of resorption in mouse gallbladder epithelium.
Peters RH, van Doorninck JH, French PJ, Ratcliff R, Evans MJ, Colledge WH, Bijman J, Scholte BJ. 
Hepatology. 1997 Feb;25(2):270-7. [IF 1997: 5.8]

Antibodies directed to the Calmodulin-binding domain of B-50 (GAP43) inhibit Ca2+-induced dopamine release from permeated synaptosomes.
Hens, J. J. H., Hoogland, G., French, P. J., Boomsma, F., and de Graan, P. N. E. (1996)
Neurosci. Res. Comm 19, 9-17 IF 0.9 in 1997]


1996
CFTR expression and mucin secretion in cultured mouse gallbladder epithelial cells. 
Peters RH, French PJ, van Doorninck JH, Lamblin G, Ratcliff R, Evans MJ, Colledge WH, Bijman J, Scholte BJ.
Am J Physiol. 1996 Dec;271(6 Pt 1):G1074-83. [IF 1997: 3.1]

A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo. 
French PJ, van Doorninck JH, Peters RH, Verbeek E, Ameen NA, Marino CR, de Jonge HR, Bijman J, Scholte BJ. 
J Clin Invest. 1996 Sep 15;98(6):1304-12. [IF 1997: 9.7]


1995
Isotype-specific activation of cystic fibrosis transmembrane conductance regulatorchloride channels by cGMP-dependent protein kinase II. 
French PJ, Bijman J, Edixhoven M, Vaandrager AB, Scholte BJ, Lohmann SM, Nairn AC, de Jonge HR. J Biol Chem. 1995 Nov 3;270(44):26626-31. [IF 1997: 7.0]

A mouse model for the cystic fibrosis delta F508 mutation.
van Doorninck JH, French PJ, Verbeek E, Peters RH, Morreau H, Bijman J, Scholte BJ. 
EMBO J. 1995 Sep 15;14(18):4403-11. [IF 1997: 12.6]

Long-lasting enhancement of synaptic excitability of CA1/subiculum neurons of the rat ventral hippocampus by vasopressin and vasopressin(4-8). 
Chepkova AN, French P, De Wied D, Ontskul AH, Ramakers GM, Skrebitski VG, Gispen WH, Urban IJ. 
Brain Res. 1995 Dec 1;701(1-2):255-66. [IF 1997: 2.1]


1993
Spontaneous morphological changes by overexpression of the growth-associated protein B-50/GAP-43 in a PC12 cell line. 
Nielander HB, French P, Oestreicher AB, Gispen WH, Schotman P.
Neurosci Lett. 1993 Nov 12;162(1-2):46-50. [IF 1997: 1.8]
 
Home